The total return over the past 12 months is -7.82% vs. +16.94% for the S&P 500. So far it's up +13.91% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (7.82%) | (81.59%) | (78.19%) | N/A | N/A | N/A |
| Total Return CAGR | (7.82%) | (81.59%) | (78.19%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | (23.66%) | (10.27%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Universe Pharmaceuticals Inc. (UPC)
| Year | Start price | End price | UPC Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.81 | $4.34 | +13.91% | +14.51% | (0.60%) |
| 2025 | $24.40 | $3.81 | (84.39%) | +17.72% | (102.11%) |
| 2024 | $1,206.00 | $24.40 | (97.98%) | +24.89% | (122.87%) |
| 2023 | $5,220.00 | $1,206.00 | (76.90%) | +26.19% | (103.09%) |
| 2022 | $5,886.00 | $5,220.00 | (11.31%) | (18.17%) | +6.86% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
